Biodesix (BDSX) Revenue (2019 - 2026)

Biodesix has reported Revenue for 8 years, with the latest figure at $25.6 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 42.3% year-over-year to $25.6 million; the trailing twelve-month figure through Mar 2026 stood at $96.1 million (up 29.05% YoY), and the FY2025 full-year result was $88.5 million, up 24.08% from the prior year.
• Revenue for Q1 2026 stood at $25.6 million, down from $28.8 million in the prior quarter.
• The five-year high for Revenue was $28.8 million in Q4 2025, with the low at $6.5 million in Q1 2022.
• Historically, Revenue has averaged $16.0 million across 5 years, with a median of $14.8 million in 2024.
• The largest YoY upside for Revenue was 70.07% in 2022 against a maximum downside of 77.32% in 2022.
• Biodesix's Revenue stood at $9.6 million in 2022, then jumped by 52.68% to $14.7 million in 2023, then surged by 39.28% to $20.4 million in 2024, then surged by 40.76% to $28.8 million in 2025, then fell by 11.13% to $25.6 million in 2026.
• The last three Revenue figures came in at $25.6 million (Q1 2026), $28.8 million (Q4 2025), and $21.8 million (Q3 2025), per Business Quant data.